High-quality medicines to treat a range of conditions
In response to the changing needs of the people we serve, we continuously develop our range of medicines, with a focus on differentiated products and delivery systems. Currently, we manufacture hundreds of generic medicines in the US.
Quick Links
Consumer Product Safety Improvement Act and CRC products
Related news
Hikma launches Palonosetron Hydrochloride Injection
29 March 2018
Hikma has launched Ritonavir Tablets USP
20 March 2018
Hikma announces global partnership with Direct Relief
15 March 2018